Evaluation of Lycopene in the Treatment of Erosive Oral Lichen Planus
Launched by NOURHAN M.ALY · Nov 26, 2020
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
Twenty erosive lichen planus patients were recruited and randomly assigned in one of two groups, the test (lycopene) and control (corticosteroids) group.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Erosive oral lichen planus patients with severe and extensive painful erythematous, erosive and/ or ulcerative lesions who are in need for systemic corticosteroid therapy
- Exclusion Criteria:
- • Pregnant females and smokers.
- • Patients suggestive of having lichenoid contact/drug reactions.
- • Patients suffering from any systemic disease as diabetes, liver disease, renal disease, any other autoimmune or collagen disease.
- • Lesions showing histological features of dysplasia.
- • Patients with skin lichen planus lesions.
About Nourhan M.Aly
Nourhan M. Aly is a dedicated clinical trial sponsor committed to advancing medical research and enhancing patient care through innovative study designs and rigorous methodologies. With a focus on therapeutic areas that address unmet medical needs, Nourhan M. Aly collaborates with healthcare professionals, regulatory bodies, and research institutions to ensure the successful execution of clinical trials. The sponsor prioritizes ethical standards and participant safety while leveraging cutting-edge technology and data analytics to drive impactful outcomes. Through strategic partnerships and a patient-centered approach, Nourhan M. Aly aims to contribute significantly to the development of new therapies and improve health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Trial Officials
Aliaa A Bedeir, BDS
Principal Investigator
Faculty of Dentistry, Alexandria University, Egypt
Azza M Zaki, PhD
Study Director
Faculty of Dentistry, Alexandria University, Egypt
Sabah A Mahmoud, PhD
Study Director
Faculty of Medicine, Alexandria University, Egypt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials